These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
685 related articles for article (PubMed ID: 16307000)
1. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy. Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000 [TBL] [Abstract][Full Text] [Related]
2. A canine minidystrophin is functional and therapeutic in mdx mice. Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277 [TBL] [Abstract][Full Text] [Related]
3. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413 [TBL] [Abstract][Full Text] [Related]
4. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
5. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype. Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500 [TBL] [Abstract][Full Text] [Related]
8. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex. Judge LM; Haraguchiln M; Chamberlain JS J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668 [TBL] [Abstract][Full Text] [Related]
9. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). Athanasopoulos T; Graham IR; Foster H; Dickson G Gene Ther; 2004 Oct; 11 Suppl 1():S109-21. PubMed ID: 15454965 [TBL] [Abstract][Full Text] [Related]
10. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle. Rafael JA; Brown SC Microsc Res Tech; 2000 Feb 1-15; 48(3-4):155-66. PubMed ID: 10679963 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302 [TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295 [TBL] [Abstract][Full Text] [Related]
13. Full-length dystrophin gene transfer to the mdx mouse in utero. Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052 [TBL] [Abstract][Full Text] [Related]
14. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597 [TBL] [Abstract][Full Text] [Related]
15. Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Sakamoto M; Yuasa K; Yoshimura M; Yokota T; Ikemoto T; Suzuki M; Dickson G; Miyagoe-Suzuki Y; Takeda S Biochem Biophys Res Commun; 2002 May; 293(4):1265-72. PubMed ID: 12054513 [TBL] [Abstract][Full Text] [Related]
16. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice. Wang B; Li J; Fu FH; Xiao X J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234 [TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610 [TBL] [Abstract][Full Text] [Related]
18. [Adeno-associated virus vector carrying human minidystrophin gene SMCKA3999 effectively ameliorates dystrophic pathology in mdx model mice]. Li HH; Zhang SM; Fang SY; Chen CL; Luo YD; Guan Y; Wang DW; Xiao X Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1513-6. PubMed ID: 14521733 [TBL] [Abstract][Full Text] [Related]
19. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015 [TBL] [Abstract][Full Text] [Related]